Katheryne Richardson, a former senior global pricing strategist at Bristol-Myers Squibb (BMS) and longtime vice president of Apexus, this week [...] …
Category: Providers
The 340B program is increasing healthcare costs for employers and driving hospital consolidation, argued panelists at a recent healthcare purchaser [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
Lilly Sues HHS, HRSA to Implement Expansive 340B Rebate for All Products and Covered Entity Types
Eli Lilly on Thursday sued the federal government to implement a sweeping 340B rebate model that would apply to all [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Johnson & Johnson’s (J&J’s) lawsuit challenging the federal government’s opposition to 340B rebates will test whether the Trump administration is [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
With one outspoken critic of the 340B program and one key supporter set to hold influential positions in the new [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators are exploring a data repository to identify 340B claims to exclude from certain Medicare inflation rebates in 2026 [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Johnson & Johnson (J&J) earlier today sued the federal government to establish a 340B rebate model, marking the latest escalation [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
With just over half of the expected vote total counted, it’s too early to tell whether California voters will approve [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Arkansas state officials and providers are urging the U.S. Supreme Court not to take up a drug industry trade group’s [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …